AzTrials
AzTrials

Kidney CalculiNCT06178575

Apply Machine Learning to the Interpretation of Urinary Crystal Morphology.

An observational study of Kidney Calculi, run by Yi-Shiou Tseng.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to developing an image-based artificial intelligence software that can automatically interpret the types and sizes of crystals in urine. The main question[s] it aims to answer are: Allowing healthcare professionals to input urine images and receive real-time reading results on… Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Kidney Calculi
How many people
200 participants
Where
No sites listed yet
Study dates
1 Jan 2024to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Calcium oxalate kidney stone patient

Who may be able to join

  • Retrospectively analyze the urine crystal images preserved from the previous study 107123-E for crystal type analysis. Subsequently, conduct image preprocessing and label categorization for machine software learning and inference. The interpreted results will then be assessed for accuracy using statistical analysis software.

Who cannot join

  • Not applicable

Trial locations and contacts

No sites are listed yet.

Yi-Shiou Tseng contact

0920376341

tysgroupone@gmail.com

About this study

The goal of this observational study is to developing an image-based artificial intelligence software that can automatically interpret the types and sizes of crystals in urine. The main question[s] it aims to answer are:

  • Allowing healthcare professionals to input urine images and receive real-time reading results on crystal types and sizes.
  • This aims to provide a faster, more objective, and accurate analysis of crystals.

We anticipate delivering an image AI software suitable for practical applications, promoting the automation and accuracy of urine crystal analysis.

Read the detailed description

Kidney stones are primarily formed due to the supersaturation of ions in urine, leading to the formation of crystals. An assessment of the risk of kidney stones is based on a patient's medical history, biochemical urine tests, and various laboratory examinations. Combining these with imaging studies such as CT scans, ultrasound, and X-rays helps in diagnosing the type of kidney stones, though imaging results for smaller stones may be less accurate. Stone formation is common with a high recurrence rate, and there is a strong correlation between urine crystals and stone composition. Therefore, the analysis of urine crystals is meaningful for the diagnosis, evaluation of treatment strategies, and prevention of stone recurrence in kidney stone disease.

Microscopic analysis of urine crystals allows the observation of smaller crystals. However, manual urine microscopy is slow and time-consuming. To address this, we aim to develop artificial intelligence software to assist in the interpretation of urine crystals, providing a faster analysis. We will retrospectively analyze urine crystal images stored from previous research (Chang Gung Memorial Hospital Internal Project Research No. 107123-E) to identify crystal types. Subsequent image preprocessing and category labeling will be done to train and infer machine software. The results will be compared with manual interpretation to establish the accuracy of the software.

Conditions
Kidney Calculi
Keywords
machine learning, urinary crystal
Medical subject headings
Kidney Calculi

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06178575
Study groupRoleWhat they receive
Manual microscopic observationControl Group: Manual analysis of urine crystal images, distinguishing crystal types, recording accuracy, and analyzing the time consumed.
Machine interpretationThe urine crystal images undergo analysis for crystal types, followed by image preprocessing and category labeling for machine software learning and inference. Subsequently, the interpreted results will be subjected to statistical analysis software to assess accuracy.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Kappa statistics

    Used for comparing between a new instrument and a standard instrument to determine whether the new instrument exhibits a certain level of performance or accuracy.

    Measured: The machine requires approximately 0.5 hours to complete the interpretation of around 800 urine crystal images.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Dec 2023
  2. Study start1 Jan 2024 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06178575
Sponsor's protocol ID
112183-E
Status last verified
Dec 2023
First submitted
12 Dec 2023
Last updated
21 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This study involves retrospectively analyzing urine crystal images preserved from a previous study (Intramural Research Project Code 107123-E at Far Eastern Memorial Hospital). Subsequently, image preprocessing and category labeling will be applied to facilitate machine software learning and inference. The interpreted results will then undergo statistical analysis for accuracy using dedicated software. Participant information and experimental data are stored on a computer in a shared laboratory, with access secured through password protection to ensure data security. Participant identities are encoded for confidentiality. Once the required information is collected, the original participant identities will be linked with their respective codes. Researchers will not obtain the list of potential participants through privacy-invasive means.

Questions about this trial

What is this clinical trial studying?

An observational study of Kidney Calculi, run by Yi-Shiou Tseng.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yi-Shiou Tseng (0920376341, tysgroupone@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Kappa statistics (time frame: The machine requires approximately 0.5 hours to complete the interpretation of around 800 urine crystal images.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in